Tegaserod and IBS: a perfect match?
Grant Thompson
W
W
University of Ottawa, Ottawa, Ontario, Canada. K2H 8C4. wgthompson@rogers.com
D002400:Cathartics / Q000627:therapeutic use; D003109:Colonic Diseases, Functional / Q000188:drug therapy*; D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D008297:Male; D010817:Physician-Patient Relations; D016032:Randomized Controlled Trials as Topic / Q000592:standards; D012107:Research Design / Q000592:standards; D016896:Treatment Outcome
D002400:Cathartics; D005765:Gastrointestinal Agents; D007211:Indoles; C105050:tegaserod